| Year |
Citation |
Score |
| 2021 |
Zullig LL, Shahsahebi M, Neely B, Hyslop T, Avecilla RAV, Griffin BM, Clayton-Stiglbauer K, Coles T, Owen L, Reeve BB, Shah K, Shelby RA, Sutton L, Dinan MA, Zafar SY, et al. Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial. Bmc Family Practice. 22: 234. PMID 34794388 DOI: 10.1186/s12875-021-01569-8 |
0.315 |
|
| 2020 |
Dinan MA, Georgieva MV, Li Y, Zhang T, Harrison M, Shenolikar R, Scales CD. Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012. Journal of Geriatric Oncology. PMID 32912737 DOI: 10.1016/J.Jgo.2020.08.005 |
0.341 |
|
| 2020 |
Dinan MA, Wilson LE, Reed SD, Griggs JJ, Norton EC. Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption. Clinical Breast Cancer. PMID 32653473 DOI: 10.1016/J.Clbc.2020.05.010 |
0.42 |
|
| 2020 |
Brander DM, Oeffinger KC, Greiner MA, Dinan MA. Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E24050 |
0.317 |
|
| 2019 |
Moss HA, Havrilesky LJ, Wang FF, Georgieva MV, Hendrix LH, Dinan MA. Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer. Journal of Oncology Practice. JOP1900026. PMID 31613721 DOI: 10.1200/Jop.19.00026 |
0.377 |
|
| 2019 |
Zambeli-Ljepović A, Wang F, Dinan MA, Hyslop T, Stang MT, Roman SA, Sosa JA, Scheri RP. Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes. Surgery. PMID 31288935 DOI: 10.1016/J.Surg.2019.05.035 |
0.359 |
|
| 2019 |
Zambeli-Ljepović A, Wang F, Dinan MA, Hyslop T, Roman SA, Sosa JA, Scheri RP. Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage. The Journal of Surgical Research. 243: 189-197. PMID 31185435 DOI: 10.1016/J.Jss.2019.05.029 |
0.382 |
|
| 2019 |
Rotter J, Wilson L, Greiner MA, Pollack CE, Dinan M. Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer. Breast Cancer Research and Treatment. PMID 31028607 DOI: 10.1007/S10549-019-05248-2 |
0.401 |
|
| 2019 |
Dinan MA, Wilson LE, Reed SD. Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 245-254. PMID 30865923 DOI: 10.6004/Jnccn.2018.7097 |
0.411 |
|
| 2019 |
Rotter J, Wilson L, Greiner M, Pollack C, Dinan M. Abstract P4-09-08: Shared-patient physician networks and their impact on the uptake of genomic testing in early-stage breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P4-09-08 |
0.374 |
|
| 2019 |
Ramalingam S, Dinan M, Crawford J. OA11.03 Survival Disparities Between Academic and Community Centers in Advanced Lung Cancer in the US: Can We Bridge the Gap? Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.467 |
0.352 |
|
| 2019 |
Zambeli-Ljepovic A, Wang F, Dinan MA, Hyslop T, Stang MT, Roman SA, Sosa JA, Scheri RP. Low Risk Thyroid Cancer in Older Adults: More Extensive Surgery Comes with Increased Cost of Surveillance Journal of the American College of Surgeons. 229: S78. DOI: 10.1016/J.Jamcollsurg.2019.08.184 |
0.343 |
|
| 2018 |
Dinan MA, Li Y, Reed SD, Ann Sosa J. INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. PMID 30383499 DOI: 10.4158/Ep-2018-0253 |
0.333 |
|
| 2018 |
Ramalingam S, Dinan MA, Crawford J. Survival comparison in patients with Stage IV lung cancer in Academic versus Community Centers in the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30312680 DOI: 10.1016/J.Jtho.2018.09.007 |
0.407 |
|
| 2018 |
Dinan MA, Curtis LH, Setoguchi S, Cheung WY. Advanced imaging and hospice use in end-of-life cancer care. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29728843 DOI: 10.1007/S00520-018-4223-0 |
0.348 |
|
| 2018 |
Wilson LE, Pollack CE, Greiner MA, Dinan MA. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011. Breast Cancer Research and Treatment. PMID 29536319 DOI: 10.1007/S10549-018-4746-6 |
0.407 |
|
| 2018 |
Hanlon A, Fleming S, Hamilton AS, Dinan MA, Melloni C, Harrison MR, Khouri M, Wu X, Wilson JF, Lipscomb J, Cress RD, Anderson RT, Kimmick GG. Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT). Journal of Clinical Oncology. 36: 127-127. DOI: 10.1200/Jco.2018.36.7_Suppl.127 |
0.318 |
|
| 2018 |
Dinan MA, Georgieva M, Shenolikar R, Scales CD. Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma. Journal of Clinical Oncology. 36: 415-415. DOI: 10.1200/Jco.2018.36.6_Suppl.415 |
0.342 |
|
| 2018 |
Wilson LE, Greiner M, Altomare I, Rotter J, Dinan MA. Nationwide utilization and costs of targeted anti-cancer drugs for elderly patients with solid tumors in the United States, 2004-2015. Journal of Clinical Oncology. 36: 23-23. DOI: 10.1200/Jco.2018.36.30_Suppl.23 |
0.423 |
|
| 2018 |
Dinan M, Wilson L, Greiner M, Pollack C. Abstract P6-09-10: Provider characteristics and receipt of oncotype Dx testing in women diagnosed with early stage breast cancer using SEER-Medicare data Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-09-10 |
0.379 |
|
| 2018 |
Moss HA, Dinan M, Georgieva MV, Hendrix LH, Havrilesky LJ. Can the ASCO alternative payment model achieve cost savings in ovarian cancer care Gynecologic Oncology. 149: 17-18. DOI: 10.1016/J.Ygyno.2018.04.044 |
0.376 |
|
| 2018 |
Georgieva M, Lund J, Nielsen M, Trogdon J, Dinan M, Weinberger M, Wheeler S. The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer Value in Health. 21: S141. DOI: 10.1016/J.Jval.2018.04.951 |
0.547 |
|
| 2017 |
Ramalingam S, Dinan M, Crawford J. 4B.02 Increasing Survival in Stage IV NSCLC in Academic versus Community Based Centers in the National Cancer Database: Topic: Medical Oncology Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.029 |
0.346 |
|
| 2016 |
Kim E, Dinan M, Islam KM, Fernandes A, Schwartzberg L, Croft E, Brahmer J, Mansfield A, Hyslop T, Burke L, Crawford J. PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S308-S309. PMID 27969528 DOI: 10.1016/J.Jtho.2016.09.096 |
0.346 |
|
| 2016 |
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes K, Wheeler SB. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY. International Journal of Technology Assessment in Health Care. 1-7. PMID 27958190 DOI: 10.1017/S026646231600060X |
0.552 |
|
| 2016 |
Robinson TJ, Thomas S, Dinan MA, Roman S, Sosa JA, Hyslop T. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27528716 DOI: 10.1200/Jco.2016.67.6437 |
0.31 |
|
| 2016 |
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Wheeler SB. Patient-Centered Communication for Discussing Oncotype DX Testing. Cancer Investigation. 1-8. PMID 27124287 DOI: 10.3109/07357907.2016.1172637 |
0.503 |
|
| 2015 |
Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Carey LA, Troester MA, Wheeler SB. Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26598755 DOI: 10.1200/Jco.2015.63.2489 |
0.561 |
|
| 2015 |
Dinan MA, Li Y, Zhang Y, Stewart SB, Curtis LH, George DJ, Reed SD. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer. Clinical Genitourinary Cancer. PMID 26382223 DOI: 10.1016/J.Clgc.2015.07.006 |
0.345 |
|
| 2015 |
Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009. Jama Oncology. PMID 26313372 DOI: 10.1001/Jamaoncol.2015.2722 |
0.414 |
|
| 2015 |
Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD. Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer. Journal of Palliative Medicine. 18: 933-9. PMID 26241733 DOI: 10.1200/Jco.2013.31.15_Suppl.6554 |
0.381 |
|
| 2015 |
Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Troester MA, Carey LA, Wheeler SB. Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing. Breast Cancer Research and Treatment. 153: 191-200. PMID 26216535 DOI: 10.1007/S10549-015-3518-9 |
0.54 |
|
| 2015 |
Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009. Jama Oncology. 1: 158-66. PMID 26181015 DOI: 10.1001/Jamaoncol.2015.43 |
0.431 |
|
| 2015 |
Adam MA, Choudhury K, Dinan MA, Reed SD, Scheri RP, Blazer DG, Roman SA, Sosa JA. Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients. Annals of Surgery. PMID 26158612 DOI: 10.1097/Sla.0000000000001055 |
0.348 |
|
| 2015 |
Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26077238 DOI: 10.1200/Jco.2014.59.8391 |
0.325 |
|
| 2015 |
Goffredo P, Thomas SM, Dinan MA, Perkins JM, Roman SA, Sosa JA. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse. Jama Internal Medicine. 175: 638-40. PMID 25686394 DOI: 10.1001/Jamainternmed.2014.8020 |
0.362 |
|
| 2015 |
Ruel E, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. The Journal of Clinical Endocrinology and Metabolism. 100: 1529-36. PMID 25642591 DOI: 10.1210/Jc.2014-4332 |
0.384 |
|
| 2015 |
Dinan MA, Hirsch BR, Lyman GH. Management of chemotherapy-induced neutropenia: measuring quality, cost, and value. Journal of the National Comprehensive Cancer Network : Jnccn. 13: e1-7. PMID 25583775 DOI: 10.6004/Jnccn.2015.0014 |
0.382 |
|
| 2015 |
Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. The Journal of Clinical Endocrinology and Metabolism. 100: 115-21. PMID 25337927 DOI: 10.1210/Jc.2014-3039 |
0.377 |
|
| 2015 |
Roberts MC, Wheeler SB, Reeder-Hayes K, Dusetzina SB, Dinan M, Weinberger M. Abstract B53: Racial variation in the uptake of a 21-tumor gene assay in the Carolina Breast Cancer Study cohort Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B53 |
0.594 |
|
| 2015 |
Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Troester MA, Carey LA, Wheeler SB. Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing Breast Cancer Research and Treatment. 153: 191-200. DOI: 10.1007/s10549-015-3518-9 |
0.53 |
|
| 2014 |
Dinan MA, Schulman KA. Exploring variation in care: alternative conceptual models. Annals of Internal Medicine. 161: 835-6. PMID 25437412 DOI: 10.7326/M14-2382 |
0.311 |
|
| 2014 |
Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Annals of Surgery. 260: 601-5; discussion 60. PMID 25203876 DOI: 10.1097/Sla.0000000000000925 |
0.381 |
|
| 2014 |
Adam MA, Speicher P, Pura J, Dinan MA, Reed SD, Roman SA, Sosa JA. Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes. Annals of Surgical Oncology. 21: 3859-64. PMID 24934584 DOI: 10.1245/S10434-014-3838-8 |
0.302 |
|
| 2014 |
Dinan MA, Curtis LH, Carpenter WR, Biddle AK, Abernethy AP, Patz EF, Schulman KA, Weinberger M. Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 512-8. PMID 24736074 DOI: 10.1097/Jto.0000000000000102 |
0.556 |
|
| 2014 |
Dinan MA, Curtis LH, Setoguchi S, Cheung WY. Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients. Journal of Clinical Oncology. 32: 6529-6529. DOI: 10.1200/Jco.2014.32.15_Suppl.6529 |
0.445 |
|
| 2014 |
Dinan MA, Curtis L, Setoguchi-Iwata S, Cheung W. Association Between Diagnostic CT Utilization and Radiation Therapy at the End of Life (EOL) in Elderly Breast and Prostate Cancer Patients: 2002-2007 International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1751 |
0.38 |
|
| 2013 |
Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4188-98. PMID 24145348 DOI: 10.1200/Jco.2013.48.9021 |
0.393 |
|
| 2013 |
Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1931-43. PMID 24014598 DOI: 10.1158/1055-9965.Epi-13-0298 |
0.413 |
|
| 2013 |
Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstetrics and Gynecology. 122: 139-47. PMID 23743450 DOI: 10.1097/Aog.0B013E318291C235 |
0.37 |
|
| 2013 |
Dinan MA, Curtis LH, Carpenter WR, Biddle AK, Abernethy AP, Patz EF, Schulman KA, Weinberger M. Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology. 267: 807-17. PMID 23418003 DOI: 10.1148/Radiol.12120174 |
0.53 |
|
| 2013 |
Reed SD, Dinan MA, Schulman KA, Lyman GH. Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 15: 203-11. PMID 22975761 DOI: 10.1038/Gim.2012.119 |
0.399 |
|
| 2013 |
Reed SD, Dinan MA, Li Y, Zhang Y, Curtis LH, George DJ, Stewart SB. Resource use and costs in the last year of life among Medicare beneficiaries who died from prostate cancer versus with the disease between 2000 and 2007. Journal of Clinical Oncology. 31: 6631-6631. DOI: 10.1200/Jco.2013.31.15_Suppl.6631 |
0.347 |
|
| 2013 |
Dinan MA, Setoguchi S, Curtis LH, Cheung WY. Association between high-cost imaging and hospice use at the end of life of cancer patients. Journal of Clinical Oncology. 31: 6504-6504. DOI: 10.1200/Jco.2013.31.15_Suppl.6504 |
0.402 |
|
| 2013 |
Dinan M, Curtis L, Carpenter W, Biddle A, Abernethy A, Patz E, Schulman K, Weinberger M. Changes in Radiation Therapy, Surgery, and Costs for Treatment of Non-Small Cell Lung Cancer After the Adoption of Positron Emission Tomography: 1998-2005 International Journal of Radiation Oncology*Biology*Physics. 87: S41-S42. DOI: 10.1016/J.Ijrobp.2013.06.110 |
0.537 |
|
| 2012 |
Dinan MA, Curtis LH, Carpenter WR, Biddle AK, Abernethy AP, Patz EF, Schulman KA, Weinberger M. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2725-30. PMID 22753917 DOI: 10.1200/Jco.2011.40.4392 |
0.53 |
|
| 2012 |
Dewitt EM, Grussemeyer CA, Friedman JY, Dinan MA, Lin L, Schulman KA, Reed SD. Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 277-83. PMID 22433759 DOI: 10.1016/J.Jval.2011.11.027 |
0.315 |
|
| 2012 |
Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Lee WR, Schulman KA. Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007. International Journal of Radiation Oncology, Biology, Physics. 82: e781-6. PMID 22331001 DOI: 10.1016/J.Ijrobp.2011.11.024 |
0.348 |
|
| 2012 |
Reed SD, Dinan MA, Schulman KA, Lyman GH. Cost-effectiveness of the 21-gene recurrence score assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer. Journal of Clinical Oncology. 30: 1525-1525. DOI: 10.1200/Jco.2012.30.15_Suppl.1525 |
0.404 |
|
| 2011 |
Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Schulman KA, Lee WR. Financial implications of changes in the initial treatment of prostate cancer among Medicare beneficiaries. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 6115. PMID 28022527 DOI: 10.1200/Jco.2011.29.15_Suppl.6115 |
0.324 |
|
| 2010 |
Dinan MA, Curtis LH, Hammill BG, Patz EF, Abernethy AP, Shea AM, Schulman KA. Changes in the use and costs of diagnostic imaging among medicare beneficiaries with cancer, 1999-2006 Jama - Journal of the American Medical Association. 303: 1625-1631. PMID 20424253 DOI: 10.1001/Jama.2010.460 |
0.45 |
|
| 2010 |
Robinson TJ, Dinan MA, Dewhirst M, Garcia-Blanco MA, Pearson JL. SplicerAV: a tool for mining microarray expression data for changes in RNA processing. Bmc Bioinformatics. 11: 108. PMID 20184770 DOI: 10.1186/1471-2105-11-108 |
0.306 |
|
| Show low-probability matches. |